2013 FDA Approval
After an extensive on-site review, the FDA has determined that GRAM meets all requirements for production of parenteral drug products, both aseptically filled and terminally sterilized.
The Latest From Grand River Aseptic Manufacturing
News
Executives from GRAM and LTS Discuss Qualities of a CDMO Redefining Innovation
What are the traits that redefine innovation in fill-finish partners? GRAM’s CEO and LTS device leadership come together to discuss...
News
Embracing a Proactive Approach: What it Takes to Offer Patient-Centric CDMO Solutions
In today’s world, where customization is essential, patients have a growing expectation for accessible and comfortable medication. We are witnessing...
News
Sterile Filling Readiness in the Drug Device Delivery Ecosystem with Bausch+Ströbel, SKAN, and GRAM
Behind the Curtain: Sterile Filling Readiness in the Drug Device Delivery Ecosystem Go behind the curtain as we delve into...